Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation ; volume:19 ; number:1 ; day:3 ; month:12 ; year:2022 ; pages:1-11 ; date:12.2022
Harm reduction journal ; 19, Heft 1 (3.12.2022), 1-11, 12.2022
- Urheber
-
Corneli, Amy
Perry, Brian
Des Marais, Andrea
Choi, Yujung
Chen, Hillary
Lilly, Rebecca
Ayers, Denae
Bennett, Jesse
Kestner, Lauren
Meade, Christina S.
Sachdeva, Nidhi
McKellar, Mehri S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-022-00718-1
- URN
-
urn:nbn:de:101:1-2023021421124321252523
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corneli, Amy
- Perry, Brian
- Des Marais, Andrea
- Choi, Yujung
- Chen, Hillary
- Lilly, Rebecca
- Ayers, Denae
- Bennett, Jesse
- Kestner, Lauren
- Meade, Christina S.
- Sachdeva, Nidhi
- McKellar, Mehri S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach